Cost-benefit/cost-effectiveness research of drug abuse prevention
Subtitle: implications for programming and policy
By: editors, William J. Bukoski, Richard I. Evans.
Contributors: Bukoski, William J.; Evans, Richard I. 1922-; National Institute on Drug Abuse. Division of Epidemiology and Prevention Research
Series: NIDA research monograph -- 176; NIH publication -- no. 98-4021
Publisher: U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Division of Epidemiology and Prevention Research
Published: 1998
Place of publication: Rockville, MD
Language: eng
Number of pages: 233
Subjects: Drug abuse -- United States -- Prevention -- Finance.; Cost-Benefit Analysis.
Notes: "Based on the papers from a technical review ... held on July 28-29, 1994"--P. ii.

Includes bibliographical references.

Also available via Internet from NIDA web site. Address as of 7/21/04: http://165.112.78.61/pdf/monographs/monograph176/download176.html; current access available via PURL.
Table of contents: value: Impact of substance abuse on federal spending; value: Historical perspective on effective prevention; value: School-based approaches to drug abuse prevention: evidence for effectiveness and suggestions for determining cost-effectiveness; value: Effectiveness of prevention interventions with youth at high risk of drug abuse; value: Costs, benefits, and cost-effectiveness of comprehensive drug abuse prevention; value: Overview of methods: cost-effectiveness, cost-benefits, and cost-offsets of prevention; value: Analytic issues for estimating the benefits and costs of substance abuse prevention; value: Benefits and costs of a family-focused methadone treatment and drug abuse prevention program: preliminary findings; value: Issues and methods in evaluating costs, benefits, and cost-effectiveness of drug abuse prevention programs for high-risk youth; value: Implications for prevention policy: a commentary.